Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Metformin"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 54841

Starter badań:

Tytuł:
Radiosensitising Effects of Metformin Added to Concomitant Chemoradiotherapy with Cisplatin in Cervical Cancer.
Autorzy:
Beduk Esen CS; Department of Radiation Oncology, Hacettepe University School of Medicine, Sihhiye, Ankara, Turkey. Electronic address: .
Gedik ME; Department of Basic Oncology, Hacettepe University Cancer Institute, Sihhiye, Ankara, Turkey. Electronic address: .
Canpinar H; Department of Basic Oncology, Hacettepe University Cancer Institute, Sihhiye, Ankara, Turkey. Electronic address: .
Yedekci FY; Department of Radiation Oncology, Hacettepe University School of Medicine, Sihhiye, Ankara, Turkey. Electronic address: .
Yildiz F; Department of Radiation Oncology, Hacettepe University School of Medicine, Sihhiye, Ankara, Turkey. Electronic address: .
Gunaydin G; Department of Radiation Oncology, Hacettepe University School of Medicine, Sihhiye, Ankara, Turkey; Department of Basic Oncology, Hacettepe University Cancer Institute, Sihhiye, Ankara, Turkey. Electronic address: .
Gultekin M; Department of Radiation Oncology, Hacettepe University School of Medicine, Sihhiye, Ankara, Turkey. Electronic address: .
Pokaż więcej
Źródło:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2023 Nov; Vol. 35 (11), pp. 744-755. Date of Electronic Publication: 2023 Sep 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Uterine Cervical Neoplasms*/drug therapy
Uterine Cervical Neoplasms*/radiotherapy
Lung Neoplasms*/radiotherapy
Female ; Humans ; Cisplatin/pharmacology ; AMP-Activated Protein Kinases/metabolism ; AMP-Activated Protein Kinases/pharmacology ; HeLa Cells ; Apoptosis ; Chemoradiotherapy ; Cell Line, Tumor
Czasopismo naukowe
Szczegóły
Tytuł:
Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose.
Autorzy:
Kuno H; Department of Nephrology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Fujimaru T; Department of Nephrology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan. .
Kadota N; Department of Nephrology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Konishi K; Department of Nephrology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Sekiguchi M; Department of Nephrology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Watanabe K; Department of Nephrology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Ito Y; Department of Nephrology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Nagahama M; Department of Nephrology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Taki F; Department of Nephrology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Hifumi T; Department of Emergency and Critical Care Medicine, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Otani N; Department of Emergency and Critical Care Medicine, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Nakayama M; Department of Nephrology, St. Luke's International Hospital, 9-1 Akashi-Cho, Chuo-Ku, Tokyo, 104-8560, Japan.
Pokaż więcej
Źródło:
CEN case reports [CEN Case Rep] 2023 Nov; Vol. 12 (4), pp. 408-412. Date of Electronic Publication: 2023 Mar 19.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Metformin*/adverse effects
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Acidosis, Lactic*/chemically induced
Diabetic Ketoacidosis*/drug therapy
Acidosis*
Female ; Humans ; Middle Aged ; Vildagliptin/therapeutic use ; Ketone Bodies/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.
Autorzy:
Zhao X; Department of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Educational Ministry of China, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Zhang X; Department of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Educational Ministry of China, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Center for Cardiovascular Diseases, The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University, Tianjin, China.
Pei J; Department of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Educational Ministry of China, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Liu Y; Department of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Educational Ministry of China, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Niu W; Department of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Educational Ministry of China, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China. .
Sun H; Department of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Educational Ministry of China, NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China. .; Center for Cardiovascular Diseases, The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University, Tianjin, China. .
Pokaż więcej
Źródło:
Diabetologia [Diabetologia] 2023 Nov; Vol. 66 (11), pp. 2139-2153. Date of Electronic Publication: 2023 Aug 15.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/metabolism
Metformin*/pharmacology
Metformin*/therapeutic use
Humans ; Mice ; Animals ; Obesity/drug therapy ; Obesity/metabolism ; Amino Acids, Branched-Chain/metabolism ; Diet, High-Fat ; Glucose
Czasopismo naukowe
Szczegóły
Tytuł:
Molecular mechanisms of action of metformin: latest advances and therapeutic implications.
Autorzy:
Zhu H; Department of Physiology and Pathophysiology, Jerry M. Wallace School of Osteopathic Medicine, Campbell University SOM, Buies Creek, NC, USA. .
Jia Z; Department of Biology, College of Arts and Sciences, University of North Carolina, Greensboro, NC, USA.
Li YR; Department of Pharmacology, Jerry M. Wallace School of Osteopathic Medicine, Campbell University, Buies Creek, NC, USA.
Danelisen I; Geisinger Commonwealth School of Medicine, Scranton, PA, USA.
Pokaż więcej
Źródło:
Clinical and experimental medicine [Clin Exp Med] 2023 Nov; Vol. 23 (7), pp. 2941-2951. Date of Electronic Publication: 2023 Apr 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/metabolism
Humans ; Hypoglycemic Agents/pharmacology ; Hypoglycemic Agents/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Effects of metformin on the gut microbiota: A systematic review.
Autorzy:
Pavlo Petakh; Department of Biochemistry and Pharmacology, Uzhhorod National University, Uzhhorod, Ukraine; Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine. Electronic address: .
Kamyshna I; Department of Medical Rehabilitation, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
Kamyshnyi A; Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine. Electronic address: .
Pokaż więcej
Źródło:
Molecular metabolism [Mol Metab] 2023 Nov; Vol. 77, pp. 101805. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:
Systematic Review; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Diabetes Mellitus, Type 2*/drug therapy
Gastrointestinal Microbiome*
Humans ; Bacteria
Czasopismo naukowe
Szczegóły
Tytuł:
Disuse-induced muscle fibrosis, cellular senescence, and senescence-associated secretory phenotype in older adults are alleviated during re-ambulation with metformin pre-treatment.
Autorzy:
Petrocelli JJ; Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA.
McKenzie AI; Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA.
de Hart NMMP; Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.
Reidy PT; Department of Kinesiology, Nutrition, and Health, Miami University, Oxford, Ohio, USA.
Mahmassani ZS; Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.
Keeble AR; Center for Muscle Biology, University of Kentucky, Lexington, Kentucky, USA.
Kaput KL; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Wahl MP; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Rondina MT; Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Marcus RL; Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA.
Welt CK; Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Holland WL; Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.
Funai K; Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.; Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.
Fry CS; Center for Muscle Biology, University of Kentucky, Lexington, Kentucky, USA.
Drummond MJ; Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA.; Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.; Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.
Pokaż więcej
Źródło:
Aging cell [Aging Cell] 2023 Nov; Vol. 22 (11), pp. e13936. Date of Electronic Publication: 2023 Jul 24.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Male ; Female ; Humans ; Senescence-Associated Secretory Phenotype ; Cellular Senescence/genetics ; Muscle, Skeletal ; Inflammation ; Walking ; Collagen ; Fibrosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Encapsulation of Selenium Nanoparticles and Metformin in Macrophage-Derived Cell Membranes for the Treatment of Spinal Cord Injury.
Autorzy:
Liu X; Pharmacy School, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; Liaoning Provincial Collaborative Innovation Center for Medical Testing and Drug Research, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.
Sun J; Pharmacy School, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; Liaoning Provincial Collaborative Innovation Center for Medical Testing and Drug Research, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.
Du J; Pharmacy School, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; Liaoning Provincial Collaborative Innovation Center for Medical Testing and Drug Research, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.
An J; Pharmacy School, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; Liaoning Provincial Collaborative Innovation Center for Medical Testing and Drug Research, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.
Li Y; Pharmacy School, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; Liaoning Provincial Collaborative Innovation Center for Medical Testing and Drug Research, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.
Hu Y; Liaoning Provincial Collaborative Innovation Center for Medical Testing and Drug Research, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; School of Basic Medicine, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.
Xiong Y; Laboratoire Catalyse et Spectrochimie (LCS), Normandie Université, ENSICAEN, UNICAEN, CNRS, Caen 14050, France.
Yu Y; Medical College of Jinzhou Medical University, Jinzhou Medical University, Jinzhou, Liaoning 121010, China.
Tian H; Liaoning Provincial Collaborative Innovation Center for Medical Testing and Drug Research, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; School of Basic Medicine, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.
Mei X; Liaoning Provincial Collaborative Innovation Center for Medical Testing and Drug Research, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; Key Laboratory of Medical Tissue Engineering of Liaoning Province, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.
Wu C; Pharmacy School, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; Liaoning Provincial Collaborative Innovation Center for Medical Testing and Drug Research, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.; Key Laboratory of Medical Tissue Engineering of Liaoning Province, Jinzhou Medical University, Jinzhou, Liaoning 121001, China.
Pokaż więcej
Źródło:
ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2023 Oct 09; Vol. 9 (10), pp. 5709-5723. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Selenium*/pharmacology
Selenium*/therapeutic use
Metformin*/pharmacology
Metformin*/therapeutic use
Spinal Cord Injuries*/drug therapy
Spinal Cord Injuries*/metabolism
Spinal Cord Injuries*/pathology
Nanoparticles*
Mice ; Animals ; Reactive Oxygen Species/metabolism ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Antioxidants/metabolism ; Macrophages/metabolism ; Macrophages/pathology ; Cell Membrane/metabolism ; Cell Membrane/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Oxidative brain and cerebellum injury in diabetes and prostate cancer model: Protective effect of metformin.
Autorzy:
Dagsuyu E; Department of Chemistry, Faculty of Engineering, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
Koroglu P; Department of Histology and Embryology, Faculty of Medicine, Halic University, Istanbul, Turkey.
Gul IB; Department of Biology, Faculty of Science, Istanbul University, Istanbul, Turkey.
Bulan OK; Department of Biology, Faculty of Science, Istanbul University, Istanbul, Turkey.
Yanardag R; Department of Chemistry, Faculty of Engineering, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
Pokaż więcej
Źródło:
Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2023 Oct; Vol. 37 (10), pp. e23440. Date of Electronic Publication: 2023 Jun 24.
Typ publikacji:
Journal Article
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Diabetes Mellitus, Experimental*/metabolism
Prostatic Neoplasms*/drug therapy
Rats ; Male ; Animals ; Humans ; Acetylcholinesterase/metabolism ; Antioxidants/metabolism ; Oxidative Stress ; Glutathione/metabolism ; Brain/metabolism ; Cerebellum/metabolism ; Streptozocin/pharmacology ; Glycoproteins/metabolism ; Glycoproteins/pharmacology ; Glycoproteins/therapeutic use ; Histone Deacetylases/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study.
Autorzy:
Zheng J; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom. Electronic address: .
Xu M; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Electronic address: .
Yang Q; MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom.
Hu C; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Walker V; MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom.
Lu J; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Wang J; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Liu R; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Xu Y; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Wang T; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhao Z; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Yuan J; Clinical Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, 518107, China; Center for Digestive Disease, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, 518107, China; Guangzhou Women and Children Medical Center, Guangzhou, Guangdong, 510623, China; Division of Epidemiology, The JC School of Public Health & Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Burgess S; MRC Biostatistics Unit, Cambridge Institute of Public Health, Cambridge, CB2 0SR, United Kingdom; Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Au Yeung SL; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Luo S; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Anderson EL; MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom; Division of Psychiatry, Faculty of Brain Sciences, University College London, London, United Kingdom.
Holmes MV; MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom.
Smith GD; MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom; NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol, United Kingdom.
Ning G; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Wang W; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Gaunt TR; MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, United Kingdom; NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol, United Kingdom. Electronic address: .
Bi Y; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Electronic address: .
Pokaż więcej
Źródło:
EBioMedicine [EBioMedicine] 2023 Oct; Vol. 96, pp. 104803. Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:
Journal Article
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Coronary Artery Disease*/genetics
Diabetes Mellitus*
Humans ; Mendelian Randomization Analysis ; Risk ; Genome-Wide Association Study ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Szczegóły
Tytuł:
High risk and low prevalence diseases: Metformin toxicities.
Autorzy:
Rivera D; Department of Emergency Medicine, UT Southwestern, Dallas, TX, USA.
Onisko N; Department of Emergency Medicine, UT Southwestern, Dallas, TX, USA.
Cao JD; Department of Emergency Medicine, UT Southwestern, Dallas, TX, USA. Electronic address: .
Koyfman A; Department of Emergency Medicine, UT Southwestern, Dallas, TX, USA.
Long B; Department of Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło:
The American journal of emergency medicine [Am J Emerg Med] 2023 Oct; Vol. 72, pp. 107-112. Date of Electronic Publication: 2023 Jul 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Metformin*/adverse effects
Diabetes Mellitus, Type 2*/drug therapy
Acidosis, Lactic*/chemically induced
Acidosis, Lactic*/epidemiology
Acidosis, Lactic*/therapy
Humans ; Hypoglycemic Agents/adverse effects ; Prevalence ; Lactic Acid
Czasopismo naukowe
Szczegóły
Tytuł:
Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance.
Autorzy:
Brīvība M; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Silamiķele L; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Kalniņa I; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Silamiķelis I; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Birzniece L; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Ansone L; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Jagare L; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Elbere I; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Kloviņš J; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Sep 19; Vol. 14, pp. 1232143. Date of Electronic Publication: 2023 Sep 19 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Insulin Resistance*
Male ; Animals ; Mice ; Female ; Diet, High-Fat/adverse effects ; NF-kappa B/metabolism ; Mice, Inbred C57BL ; Obesity/drug therapy ; Obesity/metabolism ; Insulin/therapeutic use ; Disease Models, Animal ; Immune System/metabolism ; Signal Transduction ; Immunoglobulins
Czasopismo naukowe
Szczegóły
Tytuł:
Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress-CHOP pathway.
Autorzy:
Hua L; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Yang N; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Li Y; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Huang K; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Jiang X; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Liu F; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Yu Z; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Chen J; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Lai J; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Du J; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Zeng H; Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2023 Sep; Vol. 202 (5), pp. 971-984. Date of Electronic Publication: 2023 Jul 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/metabolism
Humans ; Cell Line, Tumor ; Neoplasm Recurrence, Local ; Proto-Oncogene Proteins c-bcl-2 ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Apoptosis ; Endoplasmic Reticulum Stress
Czasopismo naukowe
Szczegóły
Tytuł:
Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia.
Autorzy:
Gayatri MB; Department of Animal Biology, School of Life Sciences, University of Hyderabad, India.
Kancha RK; Molecular Medicine and Therapeutics Laboratory, CPMB, Osmania University, Hyderabad, India.
Patchva D; Department of Pharmacology, Apollo Institute of Medical Sciences and Research, Hyderabad, India.
Velugonda N; Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, India.
Gundeti S; Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, India.
Reddy ABM; Department of Animal Biology, School of Life Sciences, University of Hyderabad, India.
Pokaż więcej
Źródło:
The FEBS journal [FEBS J] 2023 Sep; Vol. 290 (18), pp. 4480-4495. Date of Electronic Publication: 2023 May 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/metabolism
Humans ; Imatinib Mesylate/pharmacology ; Leukocytes, Mononuclear/metabolism ; Cell Line, Tumor ; Drug Resistance, Neoplasm ; Lactic Acid/metabolism ; Glucose/metabolism ; Adenosine Triphosphate ; Apoptosis
Czasopismo naukowe
Szczegóły
Tytuł:
Metformin beyond an anti-diabetic agent: A comprehensive and mechanistic review on its effects against natural and chemical toxins.
Autorzy:
Malaekeh-Nikouei A; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Shokri-Naei S; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Karbasforoushan S; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Bahari H; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Baradaran Rahimi V; Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Heidari R; Medical Biotechnology Research Center, AJA University of Medical Sciences, Tehran, Iran; Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran.
Askari VR; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran; Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Sep; Vol. 165, pp. 115263. Date of Electronic Publication: 2023 Aug 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Metformin*/metabolism
Humans ; Hypoglycemic Agents/pharmacology ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/metabolism ; Antioxidants/pharmacology ; Apoptosis ; Liver ; Inflammation/drug therapy ; Oxidative Stress
Czasopismo naukowe
Szczegóły
Tytuł:
Reversible acute blindness in suspected metformin-associated lactic acidosis: a case report.
Autorzy:
Huang R; Department of Emergency Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650000, People's Republic of China.
Sun W; Department of Plastic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, 650000, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Nov 23; Vol. 17 (1), pp. 487. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Metformin*/adverse effects
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/chemically induced
Acidosis, Lactic*/therapy
Acidosis, Lactic*/drug therapy
Acidosis*/chemically induced
Acute Kidney Injury*/chemically induced
Acute Kidney Injury*/therapy
Female ; Humans ; Middle Aged ; Hypoglycemic Agents/adverse effects ; Blindness/chemically induced
Czasopismo naukowe
Szczegóły
Tytuł:
Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa.
Autorzy:
Petrasca A; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Hambly R; Department of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.; Charles Institute of Dermatology, Dublin, Ireland.
Kearney N; Department of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.; Charles Institute of Dermatology, Dublin, Ireland.
Smith CM; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Pender EK; Department of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.; Charles Institute of Dermatology, Dublin, Ireland.
Mac Mahon J; Department of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.; Charles Institute of Dermatology, Dublin, Ireland.
O'Rourke AM; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Ismaiel M; Department of Surgery, St. Michael's Hospital, Dublin, Ireland.
Boland PA; Department of Surgery, St. Michael's Hospital, Dublin, Ireland.
Almeida JP; Department of Surgery, St. Michael's Hospital, Dublin, Ireland.
Kennedy C; Department of Surgery, St. Michael's Hospital, Dublin, Ireland.
Zaborowski A; Department of Surgery, St. Michael's Hospital, Dublin, Ireland.
Murphy S; Department of Plastic Reconstructive and Aesthetic Surgery, Blackrock Clinic, Dublin, Ireland.
Winter D; Department of Surgery, St. Michael's Hospital, Dublin, Ireland.
Kirby B; Department of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.; Charles Institute of Dermatology, Dublin, Ireland.
Fletcher JM; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.; School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Pokaż więcej
Źródło:
The British journal of dermatology [Br J Dermatol] 2023 Nov 16; Vol. 189 (6), pp. 730-740.
Typ publikacji:
Journal Article
MeSH Terms:
Hidradenitis Suppurativa*
Metformin*/pharmacology
Metformin*/therapeutic use
Metformin*/metabolism
Humans ; Leukocytes, Mononuclear/metabolism ; Skin/pathology ; Cytokines/metabolism ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of Treviamet® & Treviamet XR® on quality of life besides glycemic control in type 2 DM patients.
Autorzy:
Khan A; Public Health Department, Baqai Institute of Diabetology and Endocrinology, Karachi, Pakistan.
Kanpurwala MA; Department of Physiology, Karachi Institute of Medical Sciences affiliated with NUMS, Karachi, Pakistan. .
Khan RA; Diabetes, Baqai Institute of Diabetology and Endocrinology, Karachi, Pakistan.
Mahmudi NF; Primary Care Diabetes Association, Karachi, Pakistan.
Lohano V; Primary Care Diabetes Association, Karachi, Pakistan.
Ahmed S; Diabetes & Endocrinology Department, College of Family Medicine, Karachi, Pakistan.
Khan M; Memon Medical Complex, Karachi, Pakistan.
Uddin F; Memon Medical Complex, Karachi, Pakistan.
Ali SM; London School of Hygiene and Tropical Medicine, London, UK.
Saghir M; Bahria University, Islamabad, Pakistan.
Baqar Abidi SH; Institute of Business Management, Karachi, Pakistan.
Kamal J; Medical Education, College of Physicians and Surgeons Pakistan, Karachi, Pakistan.
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2023 Nov 08; Vol. 23 (1), pp. 244. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*
Metformin*/therapeutic use
Humans ; Hypoglycemic Agents/therapeutic use ; Quality of Life ; Glycated Hemoglobin ; Glycemic Control ; Prospective Studies ; Blood Glucose ; Sitagliptin Phosphate/adverse effects ; Drug Therapy, Combination
Czasopismo naukowe
Szczegóły
Tytuł:
The Effects of Oral Probiotics on Type 2 Diabetes Mellitus (T2DM): A Clinical Trial Systematic Literature Review.
Autorzy:
Paquette S; Medical Sciences Division, NOSM University, Sudbury, ON P3E 2C6, Canada.
Thomas SC; Medical Sciences Division, NOSM University, Sudbury, ON P3E 2C6, Canada.
Venkataraman K; Medical Sciences Division, NOSM University, Sudbury, ON P3E 2C6, Canada.; School of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.
Appanna VD; School of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.
Tharmalingam S; Medical Sciences Division, NOSM University, Sudbury, ON P3E 2C6, Canada.; School of Natural Sciences, Laurentian University, Sudbury, ON P3E 2C6, Canada.; Health Sciences North Research Institute, Sudbury, ON P3E 2H2, Canada.
Pokaż więcej
Źródło:
Nutrients [Nutrients] 2023 Nov 05; Vol. 15 (21). Date of Electronic Publication: 2023 Nov 05.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Metformin*
Probiotics*/therapeutic use
Humans ; Blood Glucose ; Lipids
Czasopismo naukowe
Szczegóły
Tytuł:
Metformin potentiates immunosuppressant activity and adipogenic differentiation of human umbilical cord-mesenchymal stem cells.
Autorzy:
Bajetto A; Section of Pharmacology, Department of Internal Medicine, University of Genova, 16132 Genova, Italy.
Pattarozzi A; Section of Pharmacology, Department of Internal Medicine, University of Genova, 16132 Genova, Italy.
Sirito R; Section of Obstetrics and Gynaecology, International Evangelical Hospital, 16122 Genova, Italy.
Barbieri F; Section of Pharmacology, Department of Internal Medicine, University of Genova, 16132 Genova, Italy.
Florio T; Section of Pharmacology, Department of Internal Medicine, University of Genova, 16132 Genova, Italy; IRCCS, Ospedale Policlinico San Martino, 16132 Genova, Italy. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2023 Nov; Vol. 124 (Pt B), pp. 111078. Date of Electronic Publication: 2023 Oct 14.
Typ publikacji:
Journal Article
MeSH Terms:
Metformin*/pharmacology
Mesenchymal Stem Cells*/metabolism
Humans ; Culture Media, Conditioned/metabolism ; Immunosuppressive Agents/pharmacology ; Leukocytes, Mononuclear ; PPAR gamma/metabolism ; Cell Differentiation/physiology ; Umbilical Cord ; Inflammation/metabolism ; Cells, Cultured
Czasopismo naukowe
Szczegóły
Tytuł:
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
Autorzy:
McInnes N; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Hall S; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Lochnan HA; Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Harris SB; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Punthakee Z; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Sigal RJ; Departments of Medicine, Cardiac Sciences and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Hramiak I; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Azharuddin M; LMC Diabetes and Endocrinology, Burlington, Ontario, Canada.
Liutkus JF; JF Liutkus Medicine Professional Corporation, Cambridge, Ontario, Canada.
Yale JF; McGill University, Quebec, Canada.
Sultan F; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Smith A; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Otto RE; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Sherifali D; School of Nursing, McMaster University, Hamilton, Ontario, Canada.
Liu YY; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
Gerstein HC; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Pokaż więcej
Corporate Authors:
REMIT-iGlarLixi Collaborative Group
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Nov; Vol. 25 (11), pp. 3347-3355. Date of Electronic Publication: 2023 Aug 14.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Metformin*/therapeutic use
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/complications
Humans ; Insulin Glargine/adverse effects ; Glycated Hemoglobin ; Blood Glucose/metabolism ; Hypoglycemic Agents/therapeutic use ; Life Style ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 54841

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies